Am I eligible for this trial based on my recent treatment and test results?

This is a question you may want to discuss with your doctor regarding the tislelizUMaB in canceR Patients With molEcuLar residuaL Disease clinical trial (NCT06332274). Contact the study team or your healthcare provider for specific answers.

What are the potential benefits and risks of participating in this trial?

This is a question you may want to discuss with your doctor regarding the tislelizUMaB in canceR Patients With molEcuLar residuaL Disease clinical trial (NCT06332274). Contact the study team or your healthcare provider for specific answers.

How does tislelizumab compare to other treatments I might consider?

This is a question you may want to discuss with your doctor regarding the tislelizUMaB in canceR Patients With molEcuLar residuaL Disease clinical trial (NCT06332274). Contact the study team or your healthcare provider for specific answers.

What will the treatment schedule look like, and how often will I need to visit the clinic?

This is a question you may want to discuss with your doctor regarding the tislelizUMaB in canceR Patients With molEcuLar residuaL Disease clinical trial (NCT06332274). Contact the study team or your healthcare provider for specific answers.

What kind of monitoring will be done to check for side effects or effectiveness?

This is a question you may want to discuss with your doctor regarding the tislelizUMaB in canceR Patients With molEcuLar residuaL Disease clinical trial (NCT06332274). Contact the study team or your healthcare provider for specific answers.

Are there any costs associated with participating in this trial?

This is a question you may want to discuss with your doctor regarding the tislelizUMaB in canceR Patients With molEcuLar residuaL Disease clinical trial (NCT06332274). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

tislelizUMaB in canceR Patients With molEcuLar residuaL Disease

NCT063322741 siteClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | tislelizUMaB in canceR Patients With molEcuLar residuaL Disease